Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

116
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.9K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.9K
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

600
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
600
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

127
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
127
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

4.7K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.7K
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

3.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diabetes updates and patient tools.

Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2014
Same author

Appendix a: management committee terms of reference.

Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2013
Same author

Designing a novel continuing education program for pharmacists: Lessons learned.

Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2013
Same journal

AFPC SHARP 2025 abstracts - oral and poster presentations.

Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2025
Same journal

AFPC CPERC 2025 Abstracts - Oral and Poster Presentations.

Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2025
Same journal

Pharmacists' experience with automated external defibrillators.

Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2025
Same journal

Should all pharmacies have an automated external defibrillator?

Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2025
Same journal

The landscape of automated external defibrillators in pharmacies: a preliminary survey.

Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2025
Same journal

StaffWISE project Part 2: Exploring pharmacy practice environment issues in Nova Scotia.

Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2025
See all related articles

Related Experiment Video

Updated: May 3, 2026

Automation of a Positron-emission Tomography PET Radiotracer Synthesis Protocol for Clinical Production
10:20

Automation of a Positron-emission Tomography PET Radiotracer Synthesis Protocol for Clinical Production

Published on: October 26, 2018

11.8K

Energize your pharmacy practice

Phil Emberley

    Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC
    |February 5, 2014
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    9.6K
    Novel Apparatus and Method for Drug Reinforcement
    07:32

    Novel Apparatus and Method for Drug Reinforcement

    Published on: August 20, 2010

    21.5K

    Related Experiment Videos

    Last Updated: May 3, 2026

    Automation of a Positron-emission Tomography PET Radiotracer Synthesis Protocol for Clinical Production
    10:20

    Automation of a Positron-emission Tomography PET Radiotracer Synthesis Protocol for Clinical Production

    Published on: October 26, 2018

    11.8K
    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    9.6K
    Novel Apparatus and Method for Drug Reinforcement
    07:32

    Novel Apparatus and Method for Drug Reinforcement

    Published on: August 20, 2010

    21.5K